Markets Stocks Economy Crypto Earnings Banking Energy
Home› Markets› Feature
Markets · Exclusive

Swiss stocks slide as US tightens AI chip export rules

Swiss stocks slide as US tightens AI chip export rules
Markets · 2026
Photo · Marcus Devlin for Daily Digest Invest
By Marcus Devlin Equities Correspondent Nov 17, 2026 4 min read

Swiss stocks took a hit on Tuesday, with the benchmark SMI index closing down 1.43%. The decline came as the United States announced tighter restrictions on exports of advanced AI chips, a move that rippled through global markets and deepened a selloff in technology shares.

The new rules, which target cutting-edge semiconductors used in artificial intelligence, are designed to limit certain countries' access to the most powerful chips. But their impact went far beyond chipmakers, feeding a broader "risk-off" mood in which investors pull back from assets seen as sensitive to economic growth expectations.

Even Switzerland's traditionally steadier blue-chip names were caught in the downdraft. Pharmaceutical giant Novartis slipped 1.83% despite a piece of positive company-specific news: US regulators approved its autoimmune drug Cosentyx for a new condition, polymyalgia rheumatica, an inflammatory disorder that causes muscle pain and stiffness. The approval expands the drug's label into a fresh patient population, but it wasn't enough to offset the market-wide selling pressure.

Why AI chip rules matter beyond tech

The US move is the latest escalation in a long-running effort to control the global flow of the most advanced semiconductor technology. AI chips are the engines powering everything from data centers to autonomous vehicles, and they've become a strategic asset in the competition between the US and China. Tighter export controls mean fewer of these chips can reach certain markets, which can slow the pace of AI development and dampen revenue expectations for companies across the supply chain.

But the effects aren't confined to the tech sector. When investors worry about growth, they tend to sell riskier assets first, and that can drag down stocks in unrelated industries. Switzerland's market, which is heavy on healthcare, consumer goods, and financials, isn't immune to these global shifts. As Treasury yields dip as stocks slide, the broader mood can turn cautious even in markets that seem far removed from the chip trade.

For everyday investors, the key takeaway is that a policy change in Washington can have knock-on effects in Zurich. The SMI's decline on Tuesday is a reminder that no market is an island, and that global supply chain and trade policies can move stock prices far from where they originate.

Luxury stocks feel the AI ripple

One of the more interesting angles is how the AI trade is affecting luxury goods. Richemont, the Swiss owner of Cartier and other high-end brands, was in focus after German investment bank Berenberg reiterated a "hold" rating and a price target of 170 Swiss francs on the stock. But the bank stressed that recent support for Richemont has partly come from AI-linked gains that have boosted the balance sheets of wealthy consumers.

That framing matters because it links luxury demand to the performance of AI-related stocks. When tech shares rise, the "wealth effect" kicks in: investors and executives feel richer, and they're more willing to spend on big-ticket items like luxury watches and jewelry. But if AI stocks reprice lower after tougher chip rules, that wealth effect can cool. When portfolios stop rising or become more volatile, assumptions about discretionary spending tend to get trimmed, and luxury valuations can compress.

Richemont doesn't sell semiconductors, but it can still trade like an "AI-adjacent" stock if investors believe high-end demand is being fueled by gains in AI-linked equities. Tighter US chip rules can weigh on that part of the market first, potentially reducing paper wealth and raising volatility. If that happens, investors often become less willing to pay premium valuations for luxury leaders, because the growth backdrop looks less certain.

In other words, Richemont's reputation as a defensive Swiss stock may not protect it as much as expected when the AI trade is under pressure. Valuation targets built on a strong top-end spending cycle become harder to defend if the wealth effect fades.

What it means for investors

For Swiss and global investors, Tuesday's move is a signal that the AI trade is not just a tech story. It's a macro story that can affect everything from pharma to luxury goods. The SMI's decline, even with positive news from Novartis, shows how difficult it is for individual stocks to buck a broad market trend.

Investors should watch how the US chip rules evolve and how AI-related stocks respond. If the selloff deepens, expect more volatility in markets that have benefited from AI-driven wealth creation. Conversely, if the rules are seen as manageable, the impact may be short-lived.

For now, the message is clear: in a globally connected market, a policy shift in one country can send ripples across the world. Keeping an eye on these connections can help everyday investors understand why their portfolios move, even when the news seems distant.

More from this story

Next article · Don't miss

TSX slides to six-week low as AI jitters hit tech shares

Canada's main stock index dropped to its lowest close in nearly six weeks, dragged down by tech and industrial shares as investors grew nervous ahead of Nvidia's earnings. Materials edged higher after Panama agreed to reopen talks on First Quantum's Cobre Pana

Read the story →
TSX slides to six-week low as AI jitters hit tech shares